Cannabis Use, PrEP and HIV Transmission Risk
Funded by: National Institute on Drug Abuse
Project dates: August 2021 - May 2026
Principal Investigator: Duncan, DustinProject dates: August 2021 - May 2026
Principal Investigator: Knox, Justin
PROJECT DESCRIPTION
This project sought to investigate relationships between multiple aspects of cannabis use in relation to HIV prevention behaviors (e.g., pre-exposure prophylaxis [PrEP] use, adherence, and discontinuation) and (biological vulnerability to HIV infection) in a population in the United States heavily impacted by HIV/AIDS.
Abstract on NIH RePORTERRelated Publications
Knox J, Magana C, Duncan DT, Shrader CH, Wilson A, Keedy S, Pagkas-Bather J, Chen YT, Schneider JA (2025). Cannabis use and HIV among Black sexually minoritized men: A systematic review and narrative analysis
AIDS, 39 (8), 1032-1046. doi: 10.1097/qad.0000000000004149. PMCID: PMC12122238.
Knox JR, Dolotina B, Moline T, Matthews I, Durrell M, Hanson H, Almirol E, Hotton A, Pagkas-Bather J, Chen YT, English D, Manuzak J, Rower JE, Miles C, Millar B, Jean-Louis G, Rendina HJ, Martins SS, Grov C, Hasin DS, Carrico AW, Shoptaw S, Schneider JA, Duncan DT (2023).
HIV prevention and care among Black cisgender sexual minority men and transgender women: Protocol for an HIV status-neutral cohort study using an observational-implementation hybrid approach
JMIR Research Protocols, 12, e48548. doi: 10.2196/48548. PMCID: PMC10724817.